Fluence maintains an extensive network of collaborations with non-profits, pharmaceutical organizations, clinical services, and foundations.

Our collaborators

Access Mindfulness

Access Mindfulness is a 501(c)(3) non-profit organization founded by Fluence Assistant Trainers Jayne Gumpel and David Gumpel. Both trainers were the first to assist with the production and expansion of Fluence programs. Access Mindfulness is the fiscal sponsor for the Fluence Diversity Fund, allowing tax-deductible donations to the Fund.

Beckley Psytech

Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines. Fluence is working with Beckley Psytech to develop a therapy manual and training program for 5-MeO-DMT therapy in clinical research.


Chacruna is a 501(c)(3) non-profit dedicated to education and community engagement around plant medicines. Anthropologist and founder Dr. Bia Labate has been a colleague and advisor to Fluence co-founders Dr. Elizabeth Nielsen and Dr. Ingmar Gorman throughout their years in the field of psychedelic research. Chacruna’s board members provided feedback on the development of the Fluence Diversity Fund mission, and Chacruna has published articles from Fluence. Fluence continues to support Chacruna with event sponsorship and sharing its educational programs with the Fluence community.

Journey Clinical

Journey Clinical is a membership-based organization for ketamine-assisted therapy providers. Two of Fluences’ lead trainers, Ingmar Gorman, PhD, and Casey Paleos, MD, serve on Journey’s board, and Fluence has helped to develop and deliver Journey Clinical’s in-house therapists’ training program. Therapists having trained at Fluence prior to joining Journey Clinical may receive partial exemption from Journey Clinical training requirements.

Kriya Institute

Kriya Institute Founder Raquel Bennet, PhD, was one of the first guest lecturers to speak at an event in NYC arranged by Dr. Nielson and Dr. Gorman in 2019. As a leading authority on the field of ketamine-assisted therapy, Dr. Bennett has continued to participate in the Fluence Community Forum and provided feedback on ketamine programs. The guidelines and resources of Kriya Institute are a primary resource and point of reference for all Fuence ketamine program trainees.


Menla is a 501(c)(3) non-profit retreat center affiliated with Tibet House US, a cultural and educational organization founded at the request of His Holiness the 14th Dalai Lama in 1987. Menla’s leadership has collaborated with Fluence to host retreat programs where Fluence trainees learn skills in psychedelic therapy in the beautiful surroundings of its Catskill mountain oasis. Fluence co-founders and assistant trainers also support Menla by speaking about psychedelic research at Menla and Tibet House online webinars and conferences, and Fluence regularly refers students interested in Buddhist psychology to Menla’s education programs.

Mindspace by Numinus

Mindspace Wellbeing Co-Founder Joe Flanders, PhD, attended a psychedelic integration workshop with Dr. Nielson and Dr. Gorman in 2018 in NYC, and made it his mission to bring the program to his Montreal community and Mindspace clinicians. Working with Andrew Rose, Mindspace and Fluence hosted a public program and professional training at McGill in the fall of 2019. The public program included Dr. Simon Amar, Montreal’s MDMA-assisted psychotherapy research site principal investigator, and the workshop sold out to an enthusiastic crowd of professionals. Based on this experience, Dr. Flanders and Andrew Rose created an official psychedelic harm reduction and integration therapy program at Mindspace Wellbeing and became Assistant Trainers at Fluence in 2020. Due in part to their early adoption and provision of education in psychedelic integration, Mindspace Wellbeing was acquired by Numinus in 2021.

Multidisciplinary Association for Psychedelic Studies (MAPS) & MAPS Public Benefit Corporation (MPBC)

The Multidisciplinary Association for Psychedelic Studies is a 501(c)(3) non-profit research organization which fully owns and funds MAPS Public Benefit Corporation, sponsor of the ongoing program of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) presently in clinical trials. MAPS and MPBC have played an integral role for Fluence Co-Founders Dr. Gorman and Dr. Nielson, who attended parts of the MAPS MDMA-Assisted Psychotherapy Training Program together in 2017, and who worked together on MAPS Phase 2 and 3 studies in NYC. Many of the principles, techniques, ethics, and ideas woven into the Fluence training programs were inspired by the outstanding training and professional development they experienced as MAPS trainees, clinical trial therapists, and co-principal investigators.

Fluence lead trainers Jeffrey Guss, MD, and Casey Paleos, MD, are also MAPS-trained therapists, having worked with Dr. Nielson and Dr. Gorman on MAPS Phase 2 and 3 trials in NYC. All four continue to serve as study therapists; Dr. Ingmar Gorman is a former Co-Principal Investigator, and Dr. Nielson and Dr. Paleos are current Co-Principal investigators of a MAPS Phase 3 study in NYC. Assistant Trainer David Gumpel serves as the MAPS research site’s Study Coordinator. Fluence Lead Trainer Kelan Thomas, PharmD, is also a sub-investigator for a MAPS-sponsored MDMA pharmacokinetics clinical trial at UCSF, and Assistant Trainers Joseph McCowan, PsyD, and Cristie Strongman are therapists on MAPS-sponsored research trials. The ethical approach and safety components built into the MAPS therapy training program form the basis for Fluence’s training program, and are referenced extensively throughout the curriculum.


Osmind is the leading software solution for practitioners of legal psychedelic-assisted therapy. Osmind’s technology streamlines the unique clinical and administrative workflows while strengthening the bond between practitioner and client. Fluence and Osmind have a formal partnership to provide their respective communities with training and technology for improving treatment delivery.

Phaneros Institute

Phaneros Institute is a non-profit research institute founded in 2011 by Eduardo Schenberg, PhD, in São Paulo to bring psychedelic-assisted psychotherapy to Brazil through the existing healthcare system and institutions. Fluence provides ongoing consultation to Phaneros in the development and execution of their MDMA-assisted therapy training program. Dr. Schenberg is a guest teacher in Fluence’s trainings.

Plant Parenthood

Fluence Assistant Trainer Rebecca Kronman, LCSW, began her formal education in psychedelic integration with a workshop and clinical consultation group with Dr. Nielson and Dr. Gorman in 2018. She went on to found Plant Parenthood, a harm reduction community-based organization, where she was soon joined by Fluence Assistant Trainer Andrew Rose. Plant Parenthood is in alignment with Fluence’s mission of harm reduction education and the reduction of stigma through community-based educational programs and media projects about psychedelics. Kronman and Rose’s work in this endeavour exemplifies how Fluence trainees succeed in translating their learning into professional practice, and in creating projects and initiatives that further enhance the field.

Portland Psychotherapy

Portland Psychotherapy is a psychotherapy, research, and training center in Portland, Oregon, conducting an investigator-initiated study of MDMA-assisted psychotherapy for anxiety. Fluence collaborated with Portland Psychotherapy to offer a workshop in 2020 which served as a fundraiser to support the MDMA research and educate clinicians in the local community about psychedelic integration. We continue to plan co-sponsored trainings, fundraisers, and other educational programming in the coming years and to inform the Fluence community about the work of Portland Psychotherapy.

Psychedelic Medicine Association (PMA)

Founded in 2019, the Psychedelic Medicine Association (PMA) facilitates the exchange of knowledge between clinicians and industry leaders interested in psychedelics. The PMA Advisory Board includes Fluence Co-Founder Dr. Nielson and Assistant Trainer Rebecca Kronman. All Fluence Certificate Program Participants are eligible for a discount on PMA membership.


Psychedelic.Support is a leading directory of therapy providers, groups, and accredited education related to psychedelics. Allison Feduccia, PhD, is the co-founder of Psychedelic.Support and former Senior Clinical Data Scientist at MAPS. During her time at MAPS, she was colleagues with Dr. Ingmar Gorman, where they co-authored a paper on Posttraumatic Growth in MDMA-assisted Psychotherapy. Today, Fluence and Psychedelic.Support provide mutual consultation, with many Fluence trainees listing their clinical services on the Psychedelic.Support website.


Psyon is a specialized professional facility focusing on the therapeutic use of psychedelics in the treatment of mental illness. Dr. Ingmar Gorman has co-authored papers with Psyon founders Tomáš Páleníček MD, PhD; Jiří Horáček MD, PhD; Filip Tylš MD, PhD; and Martin Brunovský MD, PhD.

PSYRES Foundation

The purpose of the PSYRES Foundation is to support research institutes and teams in the Czech Republic that study psychedelic substances. Dr. Ingmar Gorman serves on the Scientific Board of the organization.

Remedy Centre

Remedy Centre is a psychotherapy and MDMA research center in Toronto, Ontario, founded and led by MAPS therapist and researcher Dr. Anne C. Wagner. Fluence collaborated with Remedy to offer a workshop in 2020 that served as an educational opportunity for Remedy Centre clinicians and those in the local community. We continue to plan co-sponsored events and programming and inform the Fluence community about the work at Remedy Centre.

Source Research Foundation

Source Research Foundation (SRF) is a 501(c)(3) non-profit research and educational organization with an aim to connect, inspire, and support students who study psychedelic use in a variety of contexts, and to develop collaboration within the psychedelic science community. Fluence Lead Trainer Alan K. Davis, PhD, is president and founding director of the SRF. In support of enhanced diversity and increased opportunities for education in the fields of psychedelic science and medicine, Fluence supports SRF Grant recipients with free and reduced-cost education.

Spiritual Competency Academy (SCA)

The Spiritual Competency Academy (SCA; formerly the Spiritual Competency Resource Center, or SCRC) is a collaborative supporter of Fluence. By working with Fluence to offer APA-accredited Continuing Education (CE) for psychologists through a co-sponsorship arrangement, the SCRC has helped cement the professionalism and legitimacy of Fluence’s trainings, made its programs more accessible and desirable for professionals, and given professionals evidence of a high standard of quality. Fluence continues to work closely with SCA to credential all of our workshops and classes, a partnership that benefits our community of trainees.

The Swedish Network for Psychedelic Science (NPV)

The Swedish Network for Psychedelic Science (NPV Sweden) is a non-profit organization dedicated to bringing psychedelic research to Sweden. NPV Sweden featured Dr. Nielson a guest speaker at its Colloquium for Psychedelic Psychiatry in 2018, and hosted her twice more at Karolinska Institutet in Stockholm. In 2019 NPV Sweden hosted the first Fluence training for clinicians in Europe with Dr. Nielson and Dr. Gorman. Dr. Nielson is an honorary member of NPV Sweden, and provides pro-bono guidance on founding members’ research initiatives. Fluence Assistant Trainers Johan Eriksson and Michael Skragge are founding board members of NPV Sweden.


Tryp is a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs that has engaged to design and provide training for the psychotherapeutic portion of clinical trial activities. Tryp’s collaboration with Fluence will be initially focused on supporting Tryp’s upcoming Phase 2a clinical trial for eating disorders at the University of Florida. Fluence will consult on the design of psychotherapy protocols for the treatment and will provide extensive training for the therapists that will be conducting the trial.


Wavepaths provides an approach to wellbeing that reconnects us with our innate capacities to heal through music, technology and psychedelic science. Led by researcher Mendel Kaelen, Wavepaths has created an evidence-based adaptive, generative music system that allows therapists and psychedelic therapists to create truly person-centred therapeutic experiences with music for their clients. Fluence connects program participants to the Wavepaths community with free introductory sessions, exclusive workshops, and membership discounts.